Q
Qureator
Creating chips that are composed of patient-derived samples
About Qureator
Qureator specializes in the development of Curiochips, which are designed to create customizable and high-throughput 3D co-culture models. These models are used to mimic the complex microenvironments of tissues, such as the brain and tumor microenvironments, by replicating the interactions between various cell types. The company operates in the biotechnology sector, with offices in San Diego, CA, and Seoul, South Korea. Qureator's primary clients include research institutions and pharmaceutical companies that require advanced in vitro models for studying tissue physiology and pathology. The business model revolves around the sale and customization of Curiochips, which are integral to research in oncology and other fields requiring detailed tissue modeling. Revenue is generated through the direct sale of these chips and potentially through partnerships with research entities.
Source: Dealroom company dataAt a glance
- Founded
- 2016
- Headquarters
- San Diego, United States
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
SparkLabs Korea
Series A1 investor entered at this stage
HG Initiative
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Qureator on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Qureator on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.